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Abstract
We measured changes in transcranial Doppler ultrasound (TCD) and near
infrared spectroscopy (NIRS) during 70° upright tilt in patients with recurrent
vasovagal syncope (VVS, N = 20), postural tachycardia syndrome (POTS,
N = 20), and healthy controls (N = 12) aged 15–27 years old. VVS was
included if they fainted during testing within 5–15 min of upright tilt. We
combined TCD and NIRS to obtain estimates of percent change in the cere-
bral metabolic rate of oxygen consumption (CMRO2), cerebral blood flow
velocity (CBFv), and oxygen extraction fraction (OEF). Over the course of
10 min of upright tilt, CBFv decreased from a baseline of 70  5 to
63  5 cm/sec in controls and 74  3 to 64  3 cm/sec in POTS while
decreasing from 74  4 to 44  3 cm/sec in VVS. CMRO2 was unchanged in
POTS and controls during tilt while OEF increased by 19  3% and
15  3%, respectively. CMRO2 decreased by 31  3% in VVS during tilt
while OEF only increased by 7  3%. Oxyhemoglobin decreased by
1.1  1.3 lmol/kg brain tissue in controls, by 1.1  1.3 lmol/kg in POTS,
and 11.1  1.3 lmol/kg in VVS. CBFv and CMRO2 fell steadily in VVS dur-
ing upright tilt. The deficit in CMRO2 in VVS results from inadequate OEF in
the face of greatly reduced CBF.
Introduction
Syncope (fainting) is defined by a rapid onset of transient
loss of consciousness and postural tone due to global cere-
bral hypoperfusion with spontaneous recovery (Folino
et al. 2007). Systemic hypotension is present as the precipi-
tant cause. VVS causes loss of postural tone, which pro-
motes physical injury and rarely accidental death. The
most common form of syncope in the young is simple pos-
tural faint, denoted “postural vasovagal syncope” (VVS)
(Gowers 1907), and is a common form of orthostatic intol-
erance (OI). Prodromal (presyncopal) symptoms often
include lightheadedness, cognitive deficits, visual loss head-
ache, sweating, tremulousness, hyperventilation, and a
sensation of heat presaging imminent syncope (Low et al.
1995a) which relate to deficient cerebral perfusion, sympa-
thoadrenal activation, and perisyncopal vasodilation.
Indeed, an abnormal orthostatic decrease in cerebral blood
flow preceding overt syncope has been well documented
(van Lieshout et al. 2003; Hermosillo et al. 2006). The
diagnosis of VVS depends strongly on medical history
including the characteristic prodrome, appearance during
the faint and postdrome, and also by ruling out cardiac
causes of syncope (Sheldon et al. 2015). Simple faint is
most often episodic and associated with long periods of
“wellness” (Stewart 2009).
In contrast, postural tachycardia syndrome (POTS)
identifies with day-to-day chronic orthostatic intolerance
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(Schondorf and Low 1993; Low et al. 1995b). POTS is
defined in adults by OI symptoms – lightheadedness, cog-
nitive deficits, headache, sweating, tremulousness, but
absent visual loss (blackout) or the presyncopal sensation
of heat due to vasodilation – along with an excessive
increase in heart rate exceeding 30 beats/min within
10 min of orthostasis in the absence of postural hypoten-
sion (Schondorf and Low 1993). BP may even increase
(Grubb and Kosinski 1997). Larger HR orthostatic incre-
ments (~40 bpm) in association with chronic OI symp-
toms in the absence of postural hypotension are needed
to make the diagnosis of POTS in the young (Stewart
et al. 2006; Singer et al. 2012). Most often, mean cerebral
blood flow when upright decreases gradually similar to
healthy volunteers (Zhang et al. 1985). Excessively
reduced cerebral blood flow has been observed in some
POTS patients during orthostatic challenge, but it is an
inconstant finding (Del Pozzi et al. 2014). When ortho-
static stress is gradual during incremental upright tilt,
cerebral blood flow decreases similarly in POTS and con-
trol (Stewart et al. 2012). For this reason POTS is unasso-
ciated with a sudden loss of consciousness except in a
minority of POTS patients (~15–30%) who also have epi-
sodes of VVS (Sheldon et al. 2015).
The human brain is one of the most metabolically
active organs in the body and consumes approximately
3.5 mL of O2 per 100 g of brain tissue per minute vary-
ing with specific brain location and tissue type (Lassen
1959). Severe global cerebral ischemia decreases the cere-
bral metabolic rate of oxygen consumption (CMRO2) and
aerobic metabolism causing loss of cerebral function and
loss of consciousness (Tsivgoulis and Alexandrov 2008).
We hypothesized that reduced CMRO2 during
orthostasis would occur in VVS because it is identified
with global cerebral hypoperfusion and would not occur
in POTS because cerebral blood flow is preserved.
Materials and Methods
To address this hypothesis we combined near-infrared
spectroscopy (NIRS) with transcranial Doppler ultrasound
(TCD) in VVS patients, POTS patients, and healthy vol-
unteer control subjects.
Subjects
Twenty patients with a history of recurrent VVS aged
21.2  1.2 years (13 females), with 3 or more episodes
within the past 12 months, 20 POTS patients aged
22.5  2.0 years (16 females), and 12 healthy volunteers
aged 22.0  1.1 years (8 females) ranging in age from 15
to 27 years old were recruited. There were no group dif-
ferences in age range, weight, or body mass index. No
subjects were taking neurally active or vasoactive drugs.
Exclusionary criteria for all subjects included any infec-
tious or systemic disease, including diseases of the central
nervous system, any other well-characterized autonomic
disease, any endocrine, respiratory, metabolic, or cardio-
vascular diseases, competitive athletic training, recent
long-term bed rest, the use of nicotine or any other
chronic medication; excluding oral contraceptives.
Healthy volunteer control subjects
Healthy volunteer control subjects were recruited from
adolescents and young adults recruited as control subjects
for unrelated NIH studies. Control subjects with a history
of syncope or orthostatic intolerance were specifically
excluded. Volunteers were retained if they did not faint
during the tilt test.
Vasovagal syncope
Patients with Vasovagal syncope (VVS) were referred to
our center for investigation after experiencing at least
three episodes of fainting within the last 12 months. The
diagnosis of VVS was primarily based on the clinical his-
tory. Key diagnostic features included predisposing situa-
tions, prodromal symptoms, physical signs, and
postdrome recovery and symptoms (Sheldon et al. 2015).
In all patients, past fainting had been induced by pro-
longed standing and in three patients it was also triggered
by noxious stimuli. Prodromal features included pallor,
lightheadedness, nausea with abdominal discomfort,
diaphoresis usually followed by a feeling of warmth, visual
scotomata, or frank loss of vision progressing toward loss
of consciousness. By design VVS patients were recruited if
they had recurrent syncope and had postural vasovagal
syncope in the laboratory in which symptoms and signs
similar to their real-world syncope were reproduced with-
out pharmacological potentiation. Unconsciousness lasted
less than 30 sec in all VVS patients once placed supine
and most patients felt profoundly fatigued afterward.
Prior medication for syncope, if any, was stopped for at
least 2 weeks prior to participation in this study.
Although VVS patients had recurrent episodes of syncope
they lacked chronic day-to-day OI symptoms.
Postural tachycardia syndrome
Potential POTS patients for the study were selected based
on referral to our clinic for chronic orthostatic intoler-
ance lasting longer than 6 months; diagnosis was con-
firmed in our laboratory by means of a screening 70°
upright tilt test (HUT). The criteria used for POTS in
patients over 19 years old were a heart rate (HR) increase
2017 | Vol. 5 | Iss. 10 | e13286
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exceeding 30 bpm or absolute HR exceeding 120 bpm
within 10 min of tilt to 70° associated with OI symptoms
in the absence of hypotension (Freeman et al. 2011). The
criteria used for POTS in adolescents <19 years old were
an increase in HR exceeding 40 bpm or absolute HR
exceeding 120 bpm during a 10 min tilt to 70o in the
absence of hypotension (Singer et al. 2012). POTS enrol-
lees were either therapeutically na€ıve or were weaned off
medication except for oral contraceptives 2 weeks before
studies. POTS subjects experiencing syncope during
upright tilt were excluded from participation. No patients
were perimenstrual at the time of study.
During an upright tilt test of VVS, if reflex tachycardia
were excessive, erroneous diagnoses of POTS are made
because POTS is chronic orthostatic intolerance, while
episodic VVS is not. While a diagnosis of syncope by lab-
oratory testing requires a finding of hypotension, this
specifically excludes a diagnosis of POTS. Excessive tachy-
cardia preceding hypotension and bradycardia is often
part of the vasovagal response, and can be observed dur-
ing tilt table testing of patients diagnosed with VVS, who
are free of chronic day-to-day symptoms of OI, but do
have postural hypotension and therefore do not have
POTS. We have recently shown that HR increases alone
do not confer a diagnosis of POTS (Pediatrics Reference),
thus our cohort of POTS and VVS patients each represent
a unique population. JULIAN, one of the major criticisms
was due to confusion based on the increased HR after
HUT in VVS causing the reviewer to say “they have
POTS”. Perhaps you can add the PEDIATRICS paper as a
new citation to resolve this confusion.
The study was approved by the Committee for the Pro-
tection of Human Subjects (Institutional Review Board)
of New York Medical College conforming to The Declara-
tion of Helsinki. All subjects 18 years and older signed
informed consent prior to participation and those
<18 years old gave assent and their legal guardians signed
informed consent forms.
Instrumentation
Cardiopulmonary monitoring
Participants arrived for testing at 9:30 AM after a 2 h fast.
Participants were instructed about the experiment and
were instrumented. Instrumentation included a beat-to-
beat arterial blood pressure finger plethysmograph
(Finometer, FMS, Amsterdam, The Netherlands) cali-
brated against oscillometric BP. Respiratory plethysmog-
raphy (Respitrace 200, NIMS Inc., North Bay Village
Florida) was used to measure changes in respiration. A
combined capnograph and integrated pulse oximeter
(Smith Medical PM, Waukesha, WI) was used to measure
end-tidal carbon dioxide (ETCO2) and arterial oxygen
saturation. HR was measured from the beat-to-beat car-
diac electrical intervals on an electrocardiogram. We used
the ModelFlow pulse contour algorithm of the Finometer
calibrated against an Innocor inert gas rebreathing cardiac
output at baseline (Innovision, Denmark) to obtain rela-
tive values for cardiac output (CO) and total peripheral
resistance (TPR) calculated as MAP/CO.
Transcranial Doppler Ultrasound and near-
infrared spectroscopy
A 2 MHz transcranial Doppler (TCD) (Multigon, Yon-
kers, NY) insonated the left middle cerebral artery (MCA)
with the signal optimized for depth and signal strength.
TCD was used to measure changes in cerebral blood flow
velocity (CBFv). Detection of middle cerebral artery blood
flow was adjusted to measure the maximum value of
CBFv ensuring that the area of pulse wave interrogation
was centered in the artery. All measurements were moni-
tored continuously to assure that there were no sudden
positional changes during the performance of these
studies.
A continuous-wave spatially resolved near-infrared
spectrometer (NIRS) (Oxymon MKII, Artinis) was used
to monitor changes in oxygenated hemoglobin (HbO2),
deoxyhemoglobin (Hb), and Total hemoglobin (THb)
over the volume of cerebral tissue insonated by TCD
throughout the protocol (Rasmussen et al. 2007). Subjects
were instrumented with an emitter and a detector pair of
NIRS probes on the forehead over the right frontal cortex
to monitor absorption of light across the cerebral frontal
area that is primarily perfused by the MCA (Ross et al.
2014). Infrared signals produced by the cutaneous bed
were resolved through spatial resolution insuring that the
infrared signals from the brain were the only signals ana-
lyzed. NIRS was sampled at 50 Hz. Using an integrated
digital to analog converter, the sampled NIRS signal was
reconstructed as an analog signal and then resampled.
The modified Beer-Lambert law was used to calculate
micromolar changes in tissue HbO2 and Hb across time
using optical densities from near-infrared light at 780 and
850 nm. Depending upon the subject characteristics dif-
ferent differential path-length factors were used for each
individual participant (Essenpreis et al. 1993). The vol-
ume of cerebral tissue illuminated may differ between the
participants; however, within each participant the volume
of cerebral tissue was assumed constant for the duration
of the experiment. In order to index changes in blood
volume within the illuminated brain volume, changes in
THb were obtained by adding the changes in HbO2 to
the changes in Hb. The averages of Hb and HbO2 during
quiet rest were used to define baseline values.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Because these are noninvasive measurements, we made
the assumption that percent changes in CBFv estimated
percent changes in cerebral blood flow in the conduit ves-
sels feeding the frontal cortical tissue that was illuminated
by the NIRS. fMRI data suggest that MCA diameter is
constant in response orthostatic stress (Serrador et al.
2000). Most important for this investigation, literature
also indicates that percent change in CBFv in the MCA
can be used to accurately estimate percent change in cere-
bral blood flow in the MCA (Ainslie and Hoiland 2014).
Accordingly, CBFv changes are depicted graphically as
percent change and normalized to baseline values
obtained for each participant.
All analog signals were digitized at 200 Hz with custom
signal-processing software and were analyzed offline by
the same trained researcher after completion of studies in
all subjects.
Protocol
After instrumentation, subjects remained supine for
30 min to acclimate to their surroundings and the equip-
ment. Following the 30 min acclimation period, a 10 min
baseline period was recorded.
After supine measurements were complete, POTS and
control patients were tilted to 70° for 10 min; VVS
patients may have been tilted slightly longer if necessary.
For purposes of comparison we retained VVS patients
who had tilt-induced VVS between 5 and 15 min after tilt
up. An electrically driven tilt table (Cardiosystems 600,
Dallas, Texas) with a footboard was used. Changes in
cerebral oxyhemoglobin (HbO2) and deoxyhemoglobin
(Hb) concentrations were measured by NIRS while CBFv
of the MCA was measured by TCD. A priori stopping cri-
teria for fainting was defined by a rapid decrease in sys-
tolic blood pressure (SBP) to <60 mmHg or a decrease in
SBP to <80 mmHg associated with symptoms of impend-
ing loss of consciousness, severe lightheadedness, heat,
nausea, or diaphoresis.
Timed data collection
Orthostasis immediately causes rapid translocation of an
estimated 500 mL of central blood volume caudally due to
gravity. There is a transient loss of mechanical (pressure–
volume) equilibrium caused by a brief lag (~10 sec) in the
onset of neurovascular compensation; a transient decrease
in BP and reflex increase in HR occurs. Recovery of BP
and mechanical equilibrium occurs within a minute, and
usually in <30 sec. Such transient hypotension is denoted
“initial orthostatic hypotension” (IOH), a frequent but
brief response to orthostatic stress (Wieling et al. 2007).
Afterward BP stabilizes at systolic and diastolic BP typically
slightly elevated from baseline. BP usually remains stable
while HR progressively increases in POTS and also in
healthy volunteers typically reaching an asymptote between
5 and 10 min. By definition, POTS patients, but not con-
trol subjects, have excessive tachycardia and OI symptoms
as defined above. In contrast, VVS patients, as described
by Julu et al. (2003) also have BP stability which is often
followed by a prolonged intermediate phase during which
BP gradually decreases while HR increases. Thereafter,
both HR and BP fall precipitously with the onset of faint-
ing (Stewart 2013). For purposes of inter-Group compar-
ison we collected time averaged data at supine baseline,
1 min after tilt (once mechanical equilibrium is achieved),
5 min after tilt, at 10 min after tilt, and at the end of tilt
which coincided with the onset of faint in VVS patients. If
fainting occurred in <10 min we used the data at the initi-
ation of faint in place of 10 min data.
Data analysis
Mean arterial Pressure (MAP) was calculated from systolic
(SBP) and diastolic BP (DBP) as: MAP = (1/3)SBP +
(2/3)DBP. Mean CBFv was calculated from systolic CBFv
and diastolic CBFv as: mean CBFv = (1/3)systolic
CBFv + (2/3)diastolic CBFv. MAP and mean CBFv were
verified by automated multibeat time averaging.
NIRS generates relative changes in concentrations of
HbO2 and Hb (designated DHb and DHbO2 that when
summed yields DTHb). As shown by Mayhew, Jones,
Zheng, and coworkers, capillary and tissue oxygen profiles
rapidly reach a steady state dependent on capillary transit
time (~0.2 sec) and parenchymal oxygen diffusion (Zheng
et al. 2002, 2005). CBFv, DHb, DHbO2, arterial, and
venous hemoglobin saturations change relatively slowly
compared with tissue oxygen profiles permitting the use
of steady-state kinetics to estimate time varying CMRO2
such that (Ogawa et al. 1993; Jones et al. 2001; Mayhew
et al. 2001; Boas et al. 2003)
DCMRO2þCMRO2
CMRO2
 
¼ DHbvþHbv
Hbv
 
b
DTHbvþTHbv
THbv
 1 DCBF + CBF
CBF
 
(1)
where the subscript v denotes the venous compartment.
This approach was recast and validated in humans by
Boas et al. (2003) as:
1þ DCMRO2
CMRO2
 
¼
1þ DHb
Hb
 
b 1þ DCBFCBF
 
1þ DTHb
THb
  (2)
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where DHb, DHbO2, DTHb now refer to changing hemo-
globin per unit mass of cerebral cortex. Over an infinitesi-
mal time interval Dt, DCMRO2 << CMRO2, DHb<< Hb,
DTHb<<THb, and all changes approach infinitesimals.
Using a Taylor series and discarding second-order terms
(Apostol 1991)
1
1þ DTHb
THb
   1 DTHb
THb
 
(3)
and therefore
1þ dCMRO2
CMRO2
 
 1þ dHb
Hb
 
1þ dCBF
CBF
 
1 dTHb
THb
   (4)
where ‘d’, indicating an infinitesimal, has replaced ‘D’.
Assuming cross terms (i.e., dxx  dyy ) are vanishingly small
then
1þ dCMRO2
CMRO2
 
 1þ dHb
Hb
þ dCBF
CBF
 dTHb
THb
(5)
where all terms are time dependent. Subtracting 1 from
both sides and introducing the time infinitesimal dt, we
get
1
CMRO2
dCMRO2
dt
 
 1
Hb
dHb
dt
þ 1
CBF
dCBF
dt
 1
THb
dTHb
dt
(6)
Or
d ln CMRO2ð Þ
dt
 
 d ln Hbð Þ
dt
þ d ln CBFð Þ
dt
 d ln THbð Þ
dt
(7)
And integrating
ln
CMRO2 tð Þ
CMRO2 0ð Þ
 
 ln Hb tð Þ
Hb 0ð Þ
 
þ ln CBF tð Þ
CBF 0ð Þ
 
 ln THb tð Þ
THb 0ð Þ
 
(8)
where ln denotes the natural logarithm.
The fractional change in CMRO2 was obtained by taking
the exponential of the right hand side of eq. 8. We used
data from the literature to estimate Hb(0) = 35 lmol/L
per kg-tissue and THb(0) = 100 lmol/L per kg-tissue over
the cerebral tissue as per Boas et al. (2003). The Oxygen
Extraction Fraction (OEF) = CMRO2/(CBF) can be calcu-
lated from
OEF tð Þ
OEF 0ð Þ
 
¼ CMRO2 tð Þ
CMRO2 0ð Þ
 
 CBF tð Þ
CBF 0ð Þ
 
(9)
(Uludag et al. 2004)
Resting values of OEF are typically ~0.4 (Raichle et al.
2001).
Statistics
Because there were no significant differences in results
between the sexes, both male and female data were com-
bined for group analysis. During baseline and upright tilt the
measurements of arterial pressures, HR, CO, TPR, ETCO2,
CBFv via TCD, changes in Hb, HbO2, and THb via NIRS,
and estimated fractional changes in CMRO2 and in OEF
were measured or calculated. For CMRO2, we measured the
change in light reflected back following illumination from a
constant source that informs on the relative proportion of
oxygenated/deoxygenated hemoglobin. Thus, the relative
proportion of reflected light (i.e., the percent change) is the
unit of analysis. During tilt, we represented CBFv, MAP,
CMRO2, and OEF as percent changes from baseline.
We used a repeated-measures ANOVA with two factors:
study group (at two levels) and period (at four or five
levels, depending on the outcome). We were interested in a
GROUP x PERIOD interaction, in which a significant
interaction would indicate that the study groups differ at
one or more of the periods. In the case where the assump-
tion of sphericity is violated, a Greenhouse-Geisser correc-
tion to the degrees of freedom of the F-test was used.
We compared healthy volunteer control subjects, with
VVS patients and POTS patients at baseline, 1 min post
tilt, 5 min post tilt, and 10 min post tilt by two-way
ANOVA with time from tilt as a repeated measure look-
ing for Group x Time differences. Significance was set a
priori and differences were considered significant when a
P < 0.05 was achieved. All values are reported as
means  SEM. Results were calculated using SPSS 16
(SPSS Inc., Chicago IL).
Results
By design all the VVS patients developed a vasovagal faint
while upright, with hypotension and bradycardia at the
onset of fainting. None of the POTS or control subjects
had hypotension or syncope (Freeman et al. 2011).
Baseline supine results (Table 1)
Systolic, diastolic, and mean arterial pressures were not
different at baseline while supine. At baseline, HR was
higher in POTS compared to control (P < 0.05), but the
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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same as VVS. Neither CBFv nor CO differed by group.
ETCO2 was decreased for both VVS (P < 0.005) and for
POTS (P < 0.025) compared to control, but did not dif-
fer from one another.
Upright measurements
These are shown in the Table 1, and are depicted in Fig-
ures 1 and 2.
Table 1. Baseline and upright tilt characteristics.
Baseline 1 min 5 min 10 min Faint
Systolic BP (mmHg)
Control 116  4 122  4 119  3 121  4 119  3
VVS1 115  2 118  4 120  2 109  2 63  6
POTS 118  3 124  3 126  3 124  2 125  2
Diastolic BP (mmHg)
Control 56  2 63  3 66  3 64  2 63  2
VVS1,2 57  2 67  4 64  3 54  2 33  3
POTS1 61  2 68  2 71  2 70  2 71  2
Mean BP (mmHg)
Control 76  3 83  3 84  2 83  2 84  2
VVS1,2 76  2 84  3 83  2 73  2 43  2
POTS 80  2 87  2 89  2 88  2 89  4
HR (bpm)
Control 66  3 79  5 82  5 81  5 83  5
VVS1,2 67  2 96  4 103  4 108  5 69  3
POTS1 73  3 118  5 122  5 123  5 125  5
ETCO2 (Torr)
Control 40  1 38  1 38  1 38  1 38  1
VVS1 43  1 39  1 37  2 34  2 31  1
POTS 43  1 37  1 36  1 35  1 35  1
Cardiac output (L/min)
Control 5.6  .0.4 5.2  .0.4 5.3  0.4 5.3  0.4 5.3  0.4
VVS 5.0  .0.4 4.7  .0.4 4.7  0.3 4.4  0.4 2.8  0.5
POTS 5.1  .0.4 4.6  .0.4 4.7  0.3 4.6  0.3 4.6  0.3
Total peripheral resistance (mmHg/L/min)
Control 13  2 17  1 17  1 16  1 17  1
VVS1,2 14  1 20  1 17  1 14  2 13  2
POTS1 17  1 20  1 20  1 20  1 21  1
CBFv (cm/sec)
Control 70  5 66  6 64  5 63  5 63  5
VVS1,2 74  4 65  3 57  3 52  3 44  3
POTS 74  3 65  4 64  3 65  3 64  3
DHbO2 (lmol kg/tissue)
Control 0.0  0.0 1.9  0.9 1.1  1.2 0.7  1.3 .1  1.3
VVS1 0.0  0.0 5.6  0.9 6.5  1.3 7.5  1.2 11.1  1.3
POTS1 0.0  0.0 3.2  1.2 3.1  1.3 2.8  1.3 2.7  1.3
DHb (lmol kg/tissue)
Control 0.0  0.0 1.7  .0.7 2.3  0.5 2.2  0.5 2.4  0.5
VVS1,2 0  0 .1  0.5 0.2  0.7 0.2  0.8 0.8  1.3
POTS 0  0 1.7  0.6 2.1  0.6 2.3  0.6 2.4  0.6
DTHb (lmol kg/tissue)
Control 0.0  0.0 0.2  0.7 1.2  0.8 1.5  0.9 2.27  0.8
VVS1,2 0.0  0.0 5.7  1.4 6.7  1.8 7.6  1.9 10.1  2.4
POTS 0.0  0.0 1.5  1.7 1.0  1.8 0.5  1.8 0.3  1.7
CBFv, cerebral blood flow velocity; VVS, vasovagal syncope; POTS, postural tachycardia syndrome.
1Significantly different from control.
2Significantly different from POTS.
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Figure 1. Heart rate (HR), end tidal carbon dioxide (ETCO2), cardiac output (CO) and total peripheral resistance (TPR) during upright tilt for
control subjects (solid line), vasovagal syncope patients (VVS, dashed line) and postural tachycardia syndrome patients (POTS, dash and dot
line). HR is most increased above control in POTS and to a lesser degree in VVS. TPR is increased in POTS compared to control, and falls
throughout tilt in VVS.
Figure 2. Percent change mean in arterial pressure (MAP), in cerebral blood flow velocity (CBFv), in cerebral metabolic rate of oxygen
consumption (CMRO2) and in oxygen extraction fraction (OEF) during upright tilt for control subjects (solid line), vasovagal syncope patients
(VVS, dashed line) and postural tachycardia syndrome patients (POTS, dash and dot line). MAP declines in VVS but is stable in control and
POTS. CBFv and CMRO2 decline monotonically and in parallel throughout tilt in VVS. OEF increases by approximately half as much as control in
VVS. CBFv decreases equally in control and POTS, while CMRO2 is well maintained.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
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HR, ETCO2, CO, and TPR during upright tilt
(Fig. 1)
HR was significantly increased above control in POTS
(P < 0.001) and in VVS (P < 0.01). These differences per-
sisted even if the final data points (denoted faint/end)
were removed. Averaged HR in VVS was significantly
smaller than the averaged HR in POTS (P < 0.01).
ETCO2 decreased in all groups during tilt but was signif-
icantly decreased for VVS (P < 0.05) compared to control.
CO was not different for VVS except for the actual
faint. There was a tendency for a group effect for both
VVS and POTS compared to control which did not reach
significance (P = 0.16).
TPR increased initially during tilt for all groups, but
was thereafter progressively reduced only for VVS
(Group•Time P < 0.001). TPR was elevated for POTS
compared to control and maintained a significant group
difference from control throughout tilt (P < 0.001).
% Change in MAP, CBFv, CMRO2, and OEF
during upright tilt (Fig. 2)
MAP initially increased upon tilt in all groups and
remained, on average, unchanged in POTS and control
for the remainder of upright tilt. MAP fell throughout tilt
in VVS (P < 0.001).
CBFv decreased from baseline for all groups
(Ptime < 0.01). The time course was not different for con-
trol and POTS and tended to asymptote to a 10% reduc-
tion. In contrast, CBFv was progressively reduced
throughout tilt for VVS (P < 0.001).
CMRO2 was not different from baseline for control
and POTS. CMRO2 progressively decreased in VVS
throughout tilt (P < 0.001).
OEF increased from baseline in all subjects and was
not different in POTS compared to control subjects. OEF
was significantly reduced in VVS compared to control
and to POTS (both P < 0.01) indicating reduced oxygen
extraction in VVS in conjunction with decreased CBFv.
Reduced CBFv is not compensated by a reciprocal
increase in OEF and thus CMRO2 falls.
Discussion
Our new findings are that CBFv and cerebral metabolic
rate of oxygen consumption (CMRO2) fall steadily in
VVS during upright tilt. The deficit in CMRO2 results
from reduced oxygen extraction fraction (OEF) and
reduced CBF. OEF does not increase commensurate with
the reduction in CBFv in VVS. CBFv, CMRO2, and OEF
in POTS do not differ from control. OEF increases
sufficiently in POTS and control subjects to compensate
for the decrease in CBFv.
Orthostatic intolerance includes symptoms imputed to
diminished central nervous system function such as
impaired memory and thought, central fatigue, lighthead-
edness, and headache. These symptoms are common to
both VVS and POTS. In VVS lightheadedness and confu-
sion give way to loss of consciousness as hypotension-bra-
dycardia supervene. This does not occur in POTS because
hypotension is absent.
Based on our data the progression of CNS impairment
in VVS is easily understood: there is a marked and early
loss of cerebral blood flow and early reduction in CMRO2
due to reduced compensatory oxygen extraction.
CMRO2 is lower in VVS than in control early during
orthostatic stress. One explanation for decreased OEF is
that tissue oxygen is reduced to low values in VVS during
early orthostatic stress. This would maximize the vascular
to parenchyma oxygen gradient permitting the maximum
rate of oxygen consumption under such conditions.
Alternatively, an abnormal reduction in neural function
would reduce aerobic metabolism in VVS patients during
orthostatic stress limiting vascular to parenchyma oxygen
extraction and OEF.
CMRO2, CBFv, and OEF are similar in POTS and con-
trol subjects. This despite ongoing orthostatic cognitive
impairment in POTS (Ocon 2013; Ross et al. 2014),
sometimes referred to as ‘brain fog’ (Ross et al. 2013). In
past work, we used a working memory task in younger
POTS patients to demonstrate this progressive cognitive
impairment during step-wise incremental orthostatic
stress (Ocon et al. 2012). Cognitive impairment in POTS
was not associated with excessively decreased CBFv com-
pared to control subjects but rather with defective neu-
rovascular coupling (NVC) (Stewart et al. 2012) such that
neuronal task related increases in cerebral blood flow
(functional hyperemia) was absent in POTS patients (Ste-
wart et al. 2012). NVC is the relationship between neural
activity and functional hyperemia and involves interac-
tions among components of the neurovascular unit. Fur-
ther study attributed loss of NVC in POTS to oscillatory
cerebral blood flow rather than a decrease in mean CBF
(Stewart et al. 2015, 2016). Disruption of NVC has been
shown in diabetes, depression, hypertension, stroke, and
Alzheimer’s disease. However, the relationship between
NVC and cerebral oxygen consumption has yet to be
determined (Stewart et al. 2012).
A substantive decrease in CBF occurs in postural vaso-
vagal syncope, impairs cerebral oxygenation, and causes
prodromal lightheadedness and cognitive loss (brain fog)
ultimately producing loss of consciousness, perhaps the
acme of “brain fog”.
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Limitations
POTS patients contained a larger percent of females than
VVS or control groups. There were no qualitative differ-
ences in results based on gender and male and female
subjects were pooled.
This study is limited by the use of TCD and NIRS
which are indirect methods for the estimation of changes
in CBF, and they have low regional specificity. However,
postural VVS is a dynamic upright time-dependent pro-
cess and TCD + NIRS have superior time resolution
compared with, say fMRI or PET scans, and can be easily
applied during upright tilt. Use of more sophisticated
imaging tools is precluded because of the experimental
arrangement, changing position, and constant variations
of cerebral perfusion and oxygenation.
Most studies utilizing TCD to measure CBFv within
cerebral conduit vessels assume that the MCA is approxi-
mately uniform and cylindrical. In similar experiments
this assumption has served well as a useful approximation
(Aaslid et al. 2003). Results depend critically on how well
Doppler estimates of CBFv reflect changes in cerebral
blood flow during orthostatic stress. This, in turn,
depends on whether the MCA diameter remains
unchanged during orthostasis. fMRI data suggest that
MCA diameter is unchanged with orthostatic stress due
to LBNP (Serrador et al. 2000). Recent literature also
indicates that percent change in CBFv in the MCA can be
used to estimate percent change in CBF during ortho-
static challenge with a 2% bias overall (Lewis et al. 2015).
As changes in CBFv (DCBFv) are indexed to CBFv during
calculations of DCMRO2/CMRO2 our assumptions should
be valid. We also assumed that changes in TCD CBFv
correspond primarily to changes in the flow velocity of
the middle cerebral artery that also supplies blood to the
area of NIRS illumination (Rasmussen et al. 2007).
Finally, we assumed that time-dependent changes in
CMRO2, CBFv, DHb, and DHbO2 are slow with respect
to equilibration between vascular and parenchymal oxy-
genation. Under the conditions of this study these
assumptions seem reasonable (Stewart et al. 2006, 2012).
The ModelFlow method for computing cardiac output
has shortcomings. While there are no studies specifically
comparing ModelFlow cardiac output calculations to, say,
thermodilution catheter computations in patients with
presyncope or syncope, there are studies in which com-
parisons were made in intensive care patients showing
acceptable errors without consistent bias (Schloglhofer
et al. 2014).
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